Never Mind: FDA Changes Own Rules in Midstream

"Last August, the drug company KV Pharmaceutical filed for Chapter 11 bankruptcy protection after its run-in with Congress and the U.S. Food and Drug Administration (FDA). Although KV played by the rules, it experienced the capriciousness of Congress and the FDA and, shortly thereafter, the immutability of economic laws."